Subdued Growth No Barrier To Pfizer Limited (NSE:PFIZER) With Shares Advancing 28%
May 28
Have your own idea? Try our Stock Screener
Indian (NIFTY) Pharma Industry Analysis
UpdatedMay 28, 2025
DataAggregated Company Financials
Companies171
- 7D1.0%
- 3M6.5%
- 1Y13.6%
- YTDn/a
Over the last 7 days, the Pharma industry has remained flat, although notably Emcure Pharmaceuticals gained 28%. As for the the longer term, the industry is up 13% over the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 28 May 2025 | ₹19.8t | ₹4.0t | ₹592.7b | 32.2x | 33.5x | 5x |
| Fri, 25 Apr 2025 | ₹20.0t | ₹3.9t | ₹559.2b | 29.7x | 35.7x | 5.1x |
| Sun, 23 Mar 2025 | ₹19.8t | ₹3.9t | ₹559.4b | 30.3x | 35.4x | 5.1x |
| Tue, 18 Feb 2025 | ₹19.0t | ₹3.9t | ₹560.4b | 28.8x | 33.9x | 4.9x |
| Thu, 16 Jan 2025 | ₹20.0t | ₹3.8t | ₹527.0b | 33x | 38x | 5.3x |
| Sat, 14 Dec 2024 | ₹20.6t | ₹3.8t | ₹526.7b | 35.2x | 39x | 5.4x |
| Mon, 11 Nov 2024 | ₹20.8t | ₹3.8t | ₹513.1b | 37.7x | 40.6x | 5.5x |
| Wed, 09 Oct 2024 | ₹21.5t | ₹3.7t | ₹492.6b | 40.6x | 43.7x | 5.8x |
| Fri, 06 Sep 2024 | ₹21.4t | ₹3.7t | ₹492.4b | 42.5x | 43.4x | 5.7x |
| Sun, 04 Aug 2024 | ₹19.9t | ₹3.7t | ₹472.1b | 37.7x | 42.2x | 5.4x |
| Tue, 02 Jul 2024 | ₹17.6t | ₹3.6t | ₹448.3b | 34.1x | 39.3x | 4.9x |
| Thu, 30 May 2024 | ₹17.1t | ₹3.6t | ₹449.3b | 32.9x | 38.1x | 4.8x |
| Sat, 27 Apr 2024 | ₹17.0t | ₹3.5t | ₹418.1b | 34.6x | 40.6x | 4.9x |
| Mon, 25 Mar 2024 | ₹16.8t | ₹3.5t | ₹418.7b | 32.4x | 40.1x | 4.8x |
| Wed, 21 Feb 2024 | ₹17.0t | ₹3.5t | ₹418.6b | 34.9x | 40.7x | 4.9x |
| Fri, 19 Jan 2024 | ₹15.6t | ₹3.4t | ₹395.3b | 34.8x | 39.6x | 4.6x |
| Sun, 17 Dec 2023 | ₹14.3t | ₹3.4t | ₹395.2b | 32.2x | 36.2x | 4.2x |
| Tue, 14 Nov 2023 | ₹13.7t | ₹3.4t | ₹394.4b | 31.3x | 34.7x | 4.1x |
| Thu, 12 Oct 2023 | ₹13.1t | ₹3.3t | ₹369.9b | 30.1x | 35.4x | 4x |
| Sat, 09 Sep 2023 | ₹13.1t | ₹3.3t | ₹369.5b | 30.3x | 35.5x | 4x |
| Mon, 07 Aug 2023 | ₹13.0t | ₹3.2t | ₹356.8b | 29.6x | 36.4x | 4x |
| Wed, 05 Jul 2023 | ₹11.7t | ₹3.2t | ₹342.4b | 26.4x | 34.1x | 3.7x |
| Fri, 02 Jun 2023 | ₹10.8t | ₹3.2t | ₹345.0b | 25.9x | 31.2x | 3.4x |
| Sun, 30 Apr 2023 | ₹10.0t | ₹3.0t | ₹277.2b | 26.2x | 36x | 3.3x |
| Tue, 28 Mar 2023 | ₹9.4t | ₹3.0t | ₹277.5b | 23.3x | 34x | 3.2x |
| Thu, 23 Feb 2023 | ₹9.5t | ₹3.0t | ₹277.1b | 24x | 34.3x | 3.2x |
| Sat, 21 Jan 2023 | ₹9.9t | ₹2.9t | ₹275.2b | 25.6x | 35.9x | 3.4x |
| Mon, 19 Dec 2022 | ₹9.9t | ₹2.9t | ₹274.9b | 26.9x | 36.1x | 3.5x |
| Wed, 16 Nov 2022 | ₹10.2t | ₹2.9t | ₹276.4b | 25.3x | 36.8x | 3.6x |
| Fri, 14 Oct 2022 | ₹9.9t | ₹2.8t | ₹260.4b | 24.1x | 37.9x | 3.5x |
| Sun, 11 Sep 2022 | ₹9.8t | ₹2.8t | ₹261.9b | 24.2x | 37.3x | 3.5x |
| Tue, 09 Aug 2022 | ₹9.8t | ₹2.8t | ₹269.8b | 21.8x | 36.4x | 3.5x |
| Thu, 07 Jul 2022 | ₹9.4t | ₹2.8t | ₹274.6b | 21.4x | 34.2x | 3.4x |
| Sat, 04 Jun 2022 | ₹9.3t | ₹2.8t | ₹273.9b | 20.6x | 33.8x | 3.4x |
Price to Earnings Ratio
33.8x
Current Industry PE
- Investors are pessimistic on the Indian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 33.4x which is lower than its 3-year average PE of 37.2x.
- The 3-year average PS ratio of 4.3x is lower than the industry's current PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 29% per year over the last three years.
- Revenues for these companies have grown 13% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Pharma compare with similar industries?
| IN Market | 1.19% | |
| Healthcare | 1.20% | |
| Pharma | 0.98% | |
| Pharma | 0.98% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 500660 GlaxoSmithKline Pharmaceuticals | ₹3.35k | 12.2% +₹61.9b | 32.1% | PE61.2x | |
| EMCURE Emcure Pharmaceuticals | ₹1.34k | 25.3% +₹51.4b | n/a | PE37.4x | |
| ZYDUSLIFE Zydus Lifesciences | ₹925.60 | 4.0% +₹36.2b | -11.4% | PE20.6x | |
| PFIZER Pfizer | ₹5.51k | 10.7% +₹24.3b | 19.2% | PE32.8x | |
| 530019 Jubilant Pharmova | ₹1.13k | 14.0% +₹22.0b | 60.4% | PE21.4x |
